Hospital Sant Joan de Deu -ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry

    Pediatric Rheumatology , Vol. 22, Núm. 1

  2. L-serine treatment in patients with GRIN-related encephalopathy: A phase 2A, non-randomized study

    Brain, Vol. 147, Núm. 5, pp. 1653-1666

2023

  1. Relationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy

    Pediatric Neurology, Vol. 144, pp. 11-15

  2. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33

2022

  1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

2021

  1. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis

    European Child and Adolescent Psychiatry, Vol. 30, Núm. 9, pp. 1383-1390

  2. Nutrición parenteral. Nuevos nutrientes

    Tratamiento en Gastroenterología, Hepatología y Nutrición Pediátrica (Ergon), pp. 949-965

2020

  1. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

2019

  1. Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition

    JCO Precision Oncology

2017

  1. The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome

    Scientific Reports, Vol. 7, Núm. 1

  2. Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas

    Journal of Clinical Oncology, Vol. 35, Núm. 25, pp. 2934-2941

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  2. Tolerancia y eficacia de una formula extensamente hidrolizada en lactantes con alergia a proteínas de leche de vaca mediada por IgE. Estudio JUNGLO (I): Hidrolizado extenso de caseína

    Acta Pediatrica Espanola, Vol. 74, Núm. 3-4, pp. 83-90

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2013

  1. Detection of Streptococcus pneumoniae and Haemophilus influenzae Type B by Real-Time PCR from Dried Blood Spot Samples among Children with Pneumonia: A Useful Approach for Developing Countries

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement

    Clinical and Translational Oncology, Vol. 14, Núm. 4, pp. 280-286

2011

  1. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

    Intensive Care Medicine, Vol. 37, Núm. 2, pp. 272-283

2006

  1. Nutrición enteral domiciliaria en España. Resultados del registro de la Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica del año 2003

    Anales de Pediatria, Vol. 64, Núm. 3, pp. 239-243

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051